m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases
Oxidative stress (OS) refers to a state of imbalance between oxidation and antioxidation. OS is considered to be an important factor leading to aging and a range of diseases. The eyes are highly oxygen-consuming organs. Due to its continuous exposure to ultraviolet light, the eye is particularly vul...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2023-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_fbcc5f9ce73e4eed9c1d82f6833e27d5 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Yueqi Ni |e author |
| 700 | 1 | 0 | |a Hong Zhang |e author |
| 700 | 1 | 0 | |a Liang Chu |e author |
| 700 | 1 | 0 | |a Yin Zhao |e author |
| 245 | 0 | 0 | |a m6A Modification-Association with Oxidative Stress and Implications on Eye Diseases |
| 260 | |b MDPI AG, |c 2023-02-01T00:00:00Z. | ||
| 500 | |a 10.3390/antiox12020510 | ||
| 500 | |a 2076-3921 | ||
| 520 | |a Oxidative stress (OS) refers to a state of imbalance between oxidation and antioxidation. OS is considered to be an important factor leading to aging and a range of diseases. The eyes are highly oxygen-consuming organs. Due to its continuous exposure to ultraviolet light, the eye is particularly vulnerable to the impact of OS, leading to eye diseases such as corneal disease, cataracts, glaucoma, etc. The N6-methyladenosine (m6A) modification is the most investigated RNA post-transcriptional modification and participates in a variety of cellular biological processes. In this study, we review the role of m6A modification in oxidative stress-induced eye diseases and some therapeutic methods to provide a relatively overall understanding of m6A modification in oxidative stress-related eye diseases. | ||
| 546 | |a EN | ||
| 690 | |a oxidative stress | ||
| 690 | |a m6A modification | ||
| 690 | |a eye diseases | ||
| 690 | |a treatment | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Antioxidants, Vol 12, Iss 2, p 510 (2023) | |
| 787 | 0 | |n https://www.mdpi.com/2076-3921/12/2/510 | |
| 787 | 0 | |n https://doaj.org/toc/2076-3921 | |
| 856 | 4 | 1 | |u https://doaj.org/article/fbcc5f9ce73e4eed9c1d82f6833e27d5 |z Connect to this object online. |